The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.

Introduction {#s1}
============

Heart failure (HF) has recently emerged as a global health problem [@pone.0113032-Cook1]. It is a highly symptomatic syndrome that affects 2--3% of the population in high income countries especially in people above the age of 65 years [@pone.0113032-Redfield1], [@pone.0113032-Mosterd1]. Approximately 15 million (out of 900 million) Europeans and 5.8 million (out of 300 million) Americans are affected by HF [@pone.0113032-Wijeysundera1], [@pone.0113032-McMurray1]. The burden of HF has increased due to increasing elderly population as well as improved survival of patients with risks of HF such as acute myocardial infarction, hypertension and diabetes mellitus [@pone.0113032-Nagamine1], [@pone.0113032-Hines1]. In response, strategies for the effective management of the disease in the outpatient setting have been developed and applied [@pone.0113032-McMurray1]. This has led to improved survival in some countries [@pone.0113032-Wijeysundera1], [@pone.0113032-MacIntyre1], [@pone.0113032-Schaufelberger1]. In high-income countries, the economic burden of HF is high because it is associated with frequent hospital admissions [@pone.0113032-Stewart1], [@pone.0113032-RydenBergsten1]. Moreover, management of HF places significant financial burden on patients, their families/care-givers and, as indicated, society as a whole [@pone.0113032-Stewart1], [@pone.0113032-Araujo1], [@pone.0113032-Stewart2].

Until recently, little was known about the emerging problem of non-communicable forms of HF supplementing traditional pathways to the syndrome in sub-Saharan Africa. Contemporary studies from South Africa[@pone.0113032-Stewart3], [@pone.0113032-Sliwa1] and Nigeria[@pone.0113032-Ojji1]--[@pone.0113032-Ogah1] have built on historical reports to demonstrate that the aetiology, natural history and indeed case profile of HF (i.e. more women and younger individuals affected in the prime of their life) is different from high-income countries. As such, HF is now responsible for 7--10% of medical admissions in the region [@pone.0113032-Ojji1], [@pone.0113032-Ogah1], [@pone.0113032-Oyoo1]. Significantly, given its potential enormous cost implications (both related to direct health care costs and economic burden on affected individuals and their families) there is virtually no data on the economic burden of HF in sub-Saharan African countries and major populaces such as Nigeria.

Study Aims & Objectives {#s1a}
-----------------------

The aim of this study, therefore, was to determine the consumption of health care resources for the treatment of HF in Abeokuta, Nigeria and to estimate overall healthcare costs associated with its management in a large and representative cohort of affected cases. Data were used to estimate the annual cost of HF in the region to inform health care policy towards efficient use of resources to mitigate the individual to societal impact of the syndrome.

Material and Methods {#s2}
====================

Ethics Statement {#s2a}
----------------

This study was approved by the Federal Medical Center Abeokuta and University of Witwatersrand Health Research Ethics Review Committees and all the participants provided informed consent in writing, in accordance with the Declaration of Helsinki [@pone.0113032-Rits1].

Study site {#s2b}
----------

The study was undertaken at the Federal Medical Centre, Abeokuta, Ogun state, southwest Nigeria. The state has a population of about 3,751,140 inhabitants [@pone.0113032-Ogun1]. Abeokuta is the state capital and has a population of about a million people [@pone.0113032-Abeokuta1]. As described previously [@pone.0113032-Ogah1], Federal medical center Abeokuta is a tertiary institution that receives referrals from primary and secondary health facilities within and outside the state. All the patients that were discharged alive were given monthly appointments for clinical review as well as for refill of their medications. Patients pay out of pocket and many may not be able to buy medication that will last for longer period. Home based nursing care is not in existence in the city and in many parts of the country. Patients are often taken care of by their relations. Healthcare cost in the city of Abeokuta and in most parts of Nigeria is generally borne by the patient through out of pocket payment payments.

Only a small proportion of the Nigerian population has access to social health insurance [@pone.0113032-Soyibo1]--[@pone.0113032-Atlas1]. However, there exist very strong family bonding and extended family systems where poor patients are assisted by their wealthy or well-to-do family members. The limited coverage of social health insurance in Nigeria is a very big challenge to the achievement of universal health coverage and health care delivery in the country.

Study design and sample {#s2c}
-----------------------

As described previously [@pone.0113032-Ogah1], the Abeokuta HF registry was a hospital based, prospective, observational registry that ran from January 2009 to December 2010 which was established to determine the current clinical profile of HF in the city as well as to assess typical clinical outcomes and healthcare costs (the focus of this report) associated with HF. A more detailed description of the registry has been documented [@pone.0113032-Ogah1]. Briefly, all cases of HF presenting to the hospital were captured into the database. Private health facilities, primary health centres as well as health workers were sensitized on the existence of the registry with good response. To a large extent, the sample was fully representative of the population. During the period, HF was responsible for 9% of total medical admission [@pone.0113032-Ogah1] a figure that is consistent with equivalent reports from other parts of Africa [@pone.0113032-Stewart3], [@pone.0113032-Laabes1], [@pone.0113032-Oyoo1].

Data collection {#s2d}
---------------

A specific data extraction proforma was developed and used to obtain data on resource consumption in those cases enrolled in the Abeokuta HF registry. The clinical diagnostic criteria employed in the diagnosis of HF have been described elsewhere [@pone.0113032-Ogah1]. Clinical diagnoses were coded using the International Classification of Diseases (ICD-10) coding system [@pone.0113032-International1]. The proforma was used to extract the following direct outpatient and inpatient cost categories as shown in the textbox below.

Health Care Expenditure {#s2e}
-----------------------

### Direct Health Care Costs {#s2e1}

The inpatient costs include the cost of medical and nursing care, cost of investigations and drugs **(** [**Table 1**](#pone-0113032-t001){ref-type="table"} **)**. It also includes the cost of surgery and procedures as well transportation to and from the hospital. Personnel costs include the opportunity cost of medical care, nursing as well as ancillary support by other health workers. The wages of these health workers were derived from the Federal Government of Nigeria salary scales. This included their basic salary; call duty allowance, hazard allowance and housing allowance. We did not capture cost associated with purchase of medications over the counter, cost of alternative medical care which is common in Africa, aids, home modifications etc. We assume that these categories are likely to represent a very small percentage of the total costs identified from this study. We also did not capture capital costs.

10.1371/journal.pone.0113032.t001

###### Shows summary of the cost components.

![](pone.0113032.t001){#pone-0113032-t001-1}

  Cost component
  ----------------------------------------------------------------------------------------------
  A.
  B. In-patient care
  **i.** Direct cost
  Hospital care (Medical consultation)
  Nursing care, utility fees, accommodation and feeding and ward consumables including oxygen)
  Medications
  Medications
  Surgery and procedures
  Transportation
  Surgery and procedures
  ii\. Indirect cost- the days of lost work (productivity loss)
  B. Out-patient care
  **i.** Direct cost
  Clinic visits
  Laboratory investigations
  Medications
  Transportation
  ii\. Indirect cost-the days of lost work (productivity loss)

### Indirect Health Care Costs {#s2e2}

For indirect costs, the days of lost work (productivity loss) were calculated and the minimum wage used to monetize them.

### In-patient cost {#s2e3}

The standard costing table (unit costs) of the Federal Medical Center, Abeokuta for the year 2010 was used for computing the cost of consultations, hospital admissions, medical consumables, medical investigations, and drug therapy **(** [**Table 1**](#pone-0113032-t001){ref-type="table"} **)**. It was assumed that the cost of single hospital admission covers the cost of treatment in the emergency room as well as in the medical ward. The cost of medications was taken as a whole. We assumed that the cost of medications had remained unchanged throughout the year.

### Out-patient costs {#s2e4}

This was also grouped into direct and indirect costs. All the patients that were discharged alive were given monthly appointments for clinical review as well as for refill of their medications **(** [**Table 1**](#pone-0113032-t001){ref-type="table"} **)**.

Specific costs {#s2f}
--------------

### Cost of drugs {#s2f1}

The cost of drugs was based on the hospital\'s price list (which includes the tender prices plus a 10% mark up or dispensing fee). The frequency of use of the various categories of drugs was based on the findings from the HF registry. The most frequent dosage was used for cost calculation. We did not account for increase or reduction in dose of the drugs during the course of treatment. We assumed that substitution of one class or brand of medication occurred without additional costs.

### Cost of Laboratory and diagnostic tests {#s2f2}

The cost of all laboratory and diagnostic tests (haematological, biochemical, microbiological, chest radiography, electrocardiography and echocardiography) were based on the price list of the hospital in 2010. The rate of consumption of these items was also garnered from the HF registry.

### Cost of Surgery and Procedures {#s2f3}

The cost of surgeries and procedures were obtained from the Lagos State University Teaching Hospital (LASUTH), as well the Reddington multi-specialist hospital, Lagos where majority of the surgeries and procedures were performed [@pone.0113032-Falase1], [@pone.0113032-Johnson1]. The surgeries and procedures include valve surgeries, coronary angioplasty/stenting, pericardiectomies etc. Total cost was multiplied by the frequency of the surgeries and procedures.

### Estimation of indirect costs {#s2f4}

The human capital approach was used to estimate the indirect cost. The average annual earning of the patients was estimated based on their occupational group. These were used to calculate their average daily earnings. The product of the working days lost and average daily earnings provided the productivity losses associated with HF in the study and these were assigned monetary values.

Cost analyses {#s2g}
-------------

All available costs (as detailed above) associated with in-patient care, out-patient care as well as the opportunity costs associated with HF management in the city were computed for the year 2010. An annual, prevalence based approach was employed in estimating the cost of the resources used for the management HF [@pone.0113032-Stewart1]--[@pone.0113032-Araujo1], [@pone.0113032-Czech1]. Healthcare costs were then expressed in the local currency-Naira, (and converted to US Dollar \[\$US\] at a rate of 150 Nigerian Naira to \$US1 in 2010).

Results {#s3}
=======

Outpatient and inpatient costs were computed from a representative cohort of 239 HF cases over a 12-month period for the year 2010. [**Table 2**](#pone-0113032-t002){ref-type="table"} provides a summary of the study cohort used to derive all HF-related health care activities. Mean age was 58.0±15.1 years, 46.9% were female and around one third were aged ≤55 years and in the prime of their potential working life.

10.1371/journal.pone.0113032.t002

###### Sociodemographic profile of the HF subjects seen in 2010.

![](pone.0113032.t002){#pone-0113032-t002-2}

  Variable                                                   Value
  ---------------------------------------------------- ------------------
  Gender                                               
  Male (n/%)                                               127(53.1)
  Female (n/%)                                             112(46.9)
  Mean age (years)                                         58.0(15.1)
  Median age(years)                                            60
  Age range (years)                                    
  \<24                                                       8(3.3)
  25--34                                                    15(6.3)
  35--44                                                    21(8.8)
  45--54                                                    40(16.7)
  55--64                                                    59(24.7)
  65--74                                                    63(26.4)
  \> = 75                                                   33(13.8)
  Marital status                                       
  Single                                                    32(13.4)
  Married                                                  168(70.3)
  Widow/widower                                              5(2.1)
  Separated/Divorced                                        34(14.2)
  Educational level                                    
  No formal education                                       88(36.8)
  Primary (\< = 6 years)                                    60(25.1)
  Secondary (6--12 years)                                   44(18.4)
  Post-Secondary/University/Postgraduate (\>12years)        47(19.7)
  Occupation                                           
  Unemployed                                                20(8.4)
  Unskilled labour                                         146(61.1)
  Skilled labour                                            18(7.5)
  Professional                                              24(10.0)
  Pensioner/Retiree                                         31(13.0)
  Place of residence                                   
  Within Abeokuta city                                     138(57.7)
  Outside Abeokuta but within Ogun State                    53(22.2)
  Outside Abeokuta and outside Ogun State                   48(20.1)
  Monthly Income of subjects in Naira(Median value)    
  Unemployed[\*](#nt101){ref-type="table-fn"}            18000(120USD)
  Unskilled labour                                       90,000(600USD)
  Skilled labour                                        240,000(1600USD)
  Professional                                          480,000(3200USD)
  Pensioner/Retiree                                     330,000(2200USD)
  Aetiology of HF                                      
  Hypertensive HF                                          195(81.6)
  Dilated Cardiomyopathy                                    14(5.9)
  Pericardial Diseases                                       8(3.3)
  Rheumatic Heart Disease                                    4(1.7)
  Others                                                     4(1.7)
  Co-morbidities                                       
  Hypertension                                             185(77.4)
  Osteoarthritis                                            49(20.9)
  Atrial fibrillation                                       37(15.5)
  Diabetes Mellitus                                         24(10.0)
  Chronic Obstructive pulmonary disease                      7(2.9)
  Others                                                     6(2.4)

\*Allocated minimum wage in the country.

Cost of components of in-patient care {#s3a}
-------------------------------------

### Cost of hospital care {#s3a1}

The following were computed for the subjects: medical consultation (N300/day), nursing care (N200/day), utility fees(N400/day), accommodation and feeding (N900/day) and average cost of ward consumables/patient/admission (N3500/patient)The estimated cost of hospital care for the year was about 5.5 million naira (about \$U36,500).

### Cost of laboratory investigations {#s3a2}

The laboratory investigations considered in the costing is as shown in [**Table 3(A)**](#pone-0113032-t003){ref-type="table"}.The estimated cost was approximately 3.8 million naira (about \$US28, 000).

10.1371/journal.pone.0113032.t003

###### Cost of investigations (In-patient).
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  **A. In-patient Investigations**                                                                        
  ----------------------------------- ------------------- --------------- ------------ ------------------ -----------------------
  Urinalysis                                  200               88            225            45000                 300.0
  Full blood count                           1350               96            229            309150               2061.0
  Blood sugar                                 400               96            229            91600                 610.7
  Electrolyte and Urea                       2500               96            229            572500               3816.7
  Lipid profile                              3500               65            155            542500               3616.7
  Electrocardiography                        2500               96            229            572500               3816.7
  Echocardiography                           5000               92            220           1100000               7333.3
  Chest X-Ray                                2000               96            229            458000               3053.3
  Cardiac enzyme                             5000               0.8            2             10000                 66.7
  INR                                        3500               10             24            84000                 560.0
  HIV screening                               500               46            111            55500                 370.0
  Liver function tests                       3000               50            120            360000               2400.0
  **Total Cost**                                                                          **3840750**           **28005.0**
  **B. Out-patient investigations**                                                                       
  **Investigation**                    **Cost per test**   **Percent\***   **Number**   **Cost (Naira)**   **Cost (US Dollars)**
  Electrocardiography                        2500               96            197            492500               3283.3
  Electrolyte and Urea                       2500               96            197            492500               3283.3
  Total                                      5000               96            394            985000               6566.7

Note: Cost based on the hospital costing list for 2009.

Note: Calculation based on those that survived, it is assumed that same proportion on admission.

performed these investigations during follow up.

### Cost of medications {#s3a3}

This includes cost of standard drugs for the management of HF, as well as other drugs such as antituberculous drugs used for the management of T.B pericarditis. The estimated cost of drugs was N6, 565,527 (about \$US43770) **(see** [**Table 4**](#pone-0113032-t004){ref-type="table"} **).**

10.1371/journal.pone.0113032.t004

###### In-patient cost of medications.
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  Drug                        Route        Dose        Dosing   Unit cost (Naira)   Cost per daily dose(Naira)   Total Cost(Naira)   Number of subjects   Total cost in US Dollars
  -------------------------- ------- ---------------- -------- ------------------- ---------------------------- ------------------- -------------------- --------------------------
  Frusemide                    IV         40 mg          3             20                       60                     13620                227                     90.8
  Frusemide                   Oral        40 mg          3              5                       15                     3405                 227                     22.7
  Amlodipine                  Oral         5 mg          1             15                       15                      615                  41                     4.1
  Lisinopril                  Oral        10 mg          1             15                       15                     3330                 222                     22.2
  Spironolactone              Oral        25 mg          1             10                       10                     2030                 203                     13.5
  Digoxin                     Oral       0.125 mg        1              5                       5                      1015                 203                     6.8
  Carvedilol                  Oral       6.25 mg         1             25                       25                      550                  22                     3.7
  Hydrallazine                Oral        25 mg          1              5                       5                       90                   18                     0.6
  Isosorbide dinitrate        Oral        10 mg          1             220                     220                     3960                  18                     26.4
  Heparin (LMW)                SC         40 mg          1            1350                     1350                   209250                155                    1395.0
  Warfarin                    Oral        2.5 mg         1             40                       40                     1120                  28                     7.5
  Atorvastatin                Oral        10 mg          1             180                     180                     7380                  41                     49.2
  Amiodarone                  Oral        200 mg         2             20                       40                      200                  5                      1.3
  Antibiotics (Augmentin)      IV         600 mg         3             600                     1800                   399600                222                    2664.0
  Antibiotics (Augmentin)     Oral        625 mg         2             170                     340                     75480                222                    503.2
  Prednisolone                Oral        30 mg          1             30                       30                     7170                 239                     47.8
  Anti-tuberculous therapy    Oral    Multiple drugs     1             60                       60                      480                  8                      3.2
  Aspirin                     Oral        75 mg          1              2                       2                       208                 104                     1.4
  Total                                                                                                               729503                                       4863.4
  Grand Total                                                                                                         6565527                                     43770.2

Source: Federal Medical Centre, Abeokuta costing list, Median length of hospital stay = 9 days, 1 US Dollar  = 150 naira (2010).

### Cost of Surgery/Procedures {#s3a4}

As stated earlier, we estimated the cost of surgery/procedures for the few patients who were able to afford them. This was estimated to cost N1, 092, 000 (about \$US72800) -- see **[Table S1](#pone.0113032.s001){ref-type="supplementary-material"}.**

### Cost of transportation {#s3a5}

This was calculated to cost N216, 600 (about \$US1, 444) see **[Table S2](#pone.0113032.s002){ref-type="supplementary-material"}.**

### Indirect in-patient care cost {#s3a6}

This was estimated to cost N17, 806,500 Naira (\$US118, 710) -- see [**Table 5A**](#pone-0113032-t005){ref-type="table"} **.**

10.1371/journal.pone.0113032.t005

###### Indirect cost (In-patient/outpatient).
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  **A. Indirect in-patient care cost**                                                                                                                                      
  --------------------------------------- ---------------- -------------- ----------------------- ---------------- ------------------------------ ------------------------- --------------------------
  Occupation                               Monthly Income   Daily income   Daily income(Dollars)   No of Subjects   Total Income lost/day(Naira)   Income lost (Naira)\*\*   Income lost (Dollar)\*\*
  Unemployed\*                                 18000            900                  6                   20                    18000                       162000                      1080
  Unskilled                                    90000            4500                30                  146                    657000                      5913000                    39420
  Skilled                                      240000          12000                80                   18                    216000                      1944000                    12960
  Professional                                 480000          24000                160                  24                    576000                      5184000                    34560
  Pensioners                                   330000          16500                110                  31                    511500                      4603500                    30690
  Total                                       1158000          57900                386                 239                   1978500                     17806500                    118710
  **B. Indirect out-patient care cost**                                                                                                                                     
  Occupation                               Monthly Income   Daily income   Daily income(Dollars)   No of Subjects   Total Income lost/day(Naira)   Income lost (Naira)\*\*   Income lost (Dollar)\*\*
  Unemployed\*                                 18000            900                  6                   14                    12600                       151200                      1008
  Unskilled                                    90000            4500                30                  130                    585000                      7020000                    46800
  Skilled                                      240000          12000                80                   15                    180000                      2160000                    14400
  Professional                                 480000          24000                160                  21                    504000                      6048000                    40320
  Pensioners                                   330000          16500                110                  25                    412500                      4950000                    33000
  Total                                       1158000          57900                386                 205                   1694100                     20329200                    135528

Note: Income loss was based on 5 working days in a week, \*\*Income loss was based on median Los of 9 days.

Note: \*Assigned the minimum wage in Nigeria, Income loss was based on 5 working days in a week,

Because most mortality occurred early, it was assumed that 205 subjects completed follow up, 1dollar  = 150Nigerian Naira.

Cost of components of out-patient care {#s3b}
--------------------------------------

### Out-patient clinic visit {#s3b1}

This was based on the cost of medical consultations (N250/visit) and nursing/ancillary services (N200/visit). The calculated total cost was N29, 700 (\$US198 US dollar) -- see **[Table S3](#pone.0113032.s003){ref-type="supplementary-material"}.**

### Cost of out-patient investigations {#s3b2}

This was calculated for subjects who survived initial hospital admission. It was assumed that the proportion of subjects who had these tests during admission were also able to have them done during the follow up period. It was estimated to cost N985, 000 (\$US 6567 -- see [**Table 3B**](#pone-0113032-t003){ref-type="table"} **.**

### Cost of outpatient medications {#s3b3}

This is shown in **[Table S4](#pone.0113032.s004){ref-type="supplementary-material"}.** It was estimated to cost N9, 154,168 (\$US61, 028).

### Cost of outpatient transportation {#s3b4}

This constituted a greater proportion of the out-patient care cost. It was calculated as N9, 717, 000 (\$US 64,780) -- see **[Table S5](#pone.0113032.s005){ref-type="supplementary-material"}.**

### Indirect out-patient care cost {#s3b5}

This was estimated to cost about 20,329,200 Naira (\$US135, 528) -- see -[**Table 5B**](#pone-0113032-t005){ref-type="table"} **.**

Summary of in-patent and out-patient care cost {#s3c}
----------------------------------------------

The total cost of in-patient care was estimated as N34, 996, 477 (\$US301, 230). This comprised of N17, 899, 977 (50.9%, \$US114, 600) and N17, 806,500 (49.1%, \$US118, 710) for direct and in-direct costs respectively. Direct costs were responsible for 61% of in-patient care costs. About 40% of the direct cost was due to surgery/procedures. Hospitalization, medical investigations, drug therapy, and transportation accounted for 20%, 24%, 15%, and 1% respectively, of costs --see [**Table 6**](#pone-0113032-t006){ref-type="table"} **(A) and** [**Figure 1**](#pone-0113032-g001){ref-type="fig"} **.**

![Components of direct cost (In-patient).](pone.0113032.g001){#pone-0113032-g001}

10.1371/journal.pone.0113032.t006

###### Summary of various aspects of costs of in-patient/out-patient care.
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  **A. Summary of various aspects of costs of in-patient care**                            
  ---------------------------------------------------------------- ----------------------- --------------------------
  Item                                                              Total cost (in Naira)   Total Cost in US Dollars
  Hospitalization                                                          5475100                  36500.7
  Investigations                                                           3840750                   28005
  Medications                                                              6565527                  43770.2
  Surgery and procedures                                                  10920000                   72800
  Transportation                                                           216600                     1444
  Total Direct Cost                                                       17189977                   114600
  Total Indirect Cost                                                     17806500                   118710
  **Grand total**                                                       **34996477**               **233310**
  **B. Summary of various aspects of costs of out-patient care**                           
  Item                                                              Total cost (in Naira)   Total Cost in US Dollars
  Clinic visit                                                             1107000                    7380
  Investigations                                                           985000                     6567
  Medications                                                              9154168                   61028
  Transportation                                                           9717000                   64780
  Total Direct cost                                                       20963168                   139754
  Indirect cost                                                           20329200                   135528
  **Grand total**                                                       **41292368**               **275282**

[**Table 6(B)**](#pone-0113032-t006){ref-type="table"} summarizes the components and total estimated cost of out-patient care. It was estimated as N41, 292, 368 (\$US 275,282 UD dollars). Direct and in-direct costs were N20, 963,168 (\$US139, 754) and N20, 329,200 (\$US135, 528) respectively, constituting 51% and 49% of total out-patient care costs. Transportation, medications, clinic visits and medical investigations contributed 46%, 44%, 5% and 5% respectively to these costs - see **(** [**Figure 2**](#pone-0113032-g002){ref-type="fig"} **)**.

![Components of direct cost (out-patient).](pone.0113032.g002){#pone-0113032-g002}

Total cost {#s3d}
----------

The total estimated cost of care of HF in Abeokuta for the year 2010 was N76, 288,845 (\$US508, 595) translating to N319, 200 (\$US2, 128) per patient per year. The proportional contribution of in-patient and out-patient cost were 46% and 54% respectively. The contribution of various components to the total cost is shown in [**Figure 3**](#pone-0113032-g003){ref-type="fig"}.

![Percentage contribution of different components to total cost.](pone.0113032.g003){#pone-0113032-g003}

Discussion {#s4}
==========

To our knowledge this is the first systematic attempt at estimating the cost of HF in Nigeria; a major populace of sub-Saharan Africa. We have calculated the cost from an individual perspective whilst calculating the total cost per annum overall from a societal perspective. Effort was made to capture all the HF patients in the city of Abeokuta during the study period. All cases of HF presenting to the two major hospitals in the city were captured into the database. Private health facilities, primary health centres as well as health workers were sensitized on the existence of the registry with good response. To a large extent, the sample was representative of the population. During the period, HF was responsible for 9% of total medical admission similar to earlier report from other parts of Africa [@pone.0113032-Stewart3], [@pone.0113032-Laabes1], [@pone.0113032-Oyoo1]. The main findings of the study are - 1. The total cost of HF or cost per patient per year is enormous considering the context of a developing economy where out-of-pocket expenses is the main means of health care financing;2. Furthermore the estimated cost of HF was fairly distributed between in-patient and out-patient care; 3. A large proportion of direct cost for in-patient care was due to surgery and medical procedures and; 4. Out-patient medications and transportation was responsible for 90% of direct cost of out-patient care. The huge cost of HF has been well documented by several reports both at the individual and population levels. Data from the National Heart and Lung Institute of the United Kingdom shows that the cost of HF per person is approximately 8500 Pounds. At the national level HF costs about 39.2 billion US dollars in America (about 2% of US healthcare budget) [@pone.0113032-Writing1]. Similar data have been reported from other countries [@pone.0113032-Stewart1], [@pone.0113032-RydenBergsten1] [@pone.0113032-Araujo1], [@pone.0113032-Fagnani1].

The distribution of cost of HF in our setting is different from that observed in high income countries [@pone.0113032-Stewart1], [@pone.0113032-RydenBergsten1], [@pone.0113032-Fagnani1] but similar to one report from Brazil [@pone.0113032-Araujo1]. There has not been any report from Africa to compare our findings with. The contribution of hospital care cost in these countries ranged from 53--75%. Cost of outpatient care was in the range of 4--31% while the cost of drug therapy was between 6--8% of the total cost of care. The pattern of heart diseases as well as level of technological development influences the mode of care as well as utilization of sophisticated and expensive medical equipment, procedures and consumables which are obviously needed for the care of HF patients. The consumption of these is higher in high income countries than in our setting. This is clearly shown by the impact of surgery/procedures on the cost of hospital care. The few cases (out of the many that needed this) that had surgery for valvular diseases or coronary interventions escalated the hospital care cost in our study.

Other determinants of hospital cost will also include length of hospital stay [@pone.0113032-Stewart1], [@pone.0113032-Stewart2]. (in which our report is similar to European data but longer than the mean length of hospital stay in the USA) Cost of management of co-morbidities has also been shown to account for higher cost of hospitalization in high income countries. In one report on Medicare claims, HF accounted for only15% of the total in-patient cost while 57% were associated with other co-morbid conditions [@pone.0113032-Whellan1]. This may probably be responsible for the huge cost of hospitalization in high income countries compared to our environment.

Due to lack of community based or nurse-led or home care of HF patients in our setting, our patients are given shorter out-patient appointments in order to refill their medications. This is responsible for the high cost attributable to transportation in our report. Because of the younger age of our subjects, HF in our setting is, therefore, associated with longer disability adjusted life years and by extension a huge cost to the society at large.

With the changing demographic and epidemiological landscape in Nigeria coupled with the rising burden of cardiovascular risk factors and non-communicable diseases (especially hypertension) in the country, the rate of HF is predicted to rise if preventive measures are not put in place at all levels. This will put a lot of strain in an already weak health system. The high cost of surgical interventions and procedures is out of the reach of the average Nigerian. Prevention of conditions requiring this mode of care such as rheumatic heart disease, tuberculosis (because of pericarditis) and coronary artery disease should be a priority for the country at large. Furthermore the need for a functional, effective and efficient social health insurance system in the country cannot be overemphasized considering the fact that majority of those afflicted by HF are poor and are not likely to sustain the treatment of their illness for a long time. There is also need to develop community based HF care in the country as this will reduce the cost of outpatient care which is largely contributed by the cost of frequent transport to-and-from the health facility.

Limitations {#s4a}
-----------

This is a hospital based study. Although we tried as much as possible to capture all the HF cases in the city during the study period, there is still the possibility that mild cases may have been missed out especially those that were managed in the out-patient clinic.

We also did not assess cost based on the severity of HF (NYHA class). Studies have shown that those in NYHA class IV were 8--30 times more expensive to manage compared to those in NYHA class II [@pone.0113032-Czech1], [@pone.0113032-McMurray2], [@pone.0113032-McMurray3]. Age and sex-specific cost analysis was also not carried out. We also did not include the cost of co-morbidities neither did we capture cost due to alternative medicines (which is common in Africa), over the counter purchases, capital cost and indirect cost by care givers as well as the general cost to the society. These are potential areas of research in our community in the future.

Conclusion {#s4b}
----------

Our data shows the profound impact and importance of HF as a major public health problem in a developing economy like Nigeria that is still battling with communicable diseases. The annual individual cost of HF is high coupled with the fact that of pocket expenses in the country is over 90%. There is therefore need to reduce this expenditure through control of risk factors for HF in the society especially high blood pressure, reduction in hospital as well as out-patient care cost through the development of community HF care programmes in the country.
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